Zobrazeno 1 - 9
of 9
pro vyhledávání: '"de Mendoza FH"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas ES, Gomez HL, Li RK, Chung HC, Fein LE, Chan VF, Jassem J, Pivot XB, Klimovsky JV, de Mendoza FH, Xu B, Campone M, Lerzo GL, Peck RA, Mukhopadhyay P, Vahdat LT, Roché HH, Thomas, Eva S, Gomez, Henry L, Li, Rubi K
Publikováno v:
Journal of Clinical Oncology; 11/20/2007, Vol. 25 Issue 33, p5210-5217, 8p
Autor:
Pettengell R (AUTHOR), Coiffier B (AUTHOR), Narayanan G (AUTHOR), de Mendoza FH (AUTHOR), Digumarti R (AUTHOR), Gomez H (AUTHOR), Zinzani PL (AUTHOR), Schiller G (AUTHOR), Rizzieri D (AUTHOR), Boland G (AUTHOR), Cernohous P (AUTHOR), Wang L (AUTHOR), Kuepfer C (AUTHOR), Gorbatchevsky I (AUTHOR), Singer JW (AUTHOR)
Publikováno v:
Lancet Oncology. Jul2012, Vol. 13 Issue 7, p696-706. 11p.
Autor:
Paul Cernohous, Bertrand Coiffier, Raghunadharao Digumarti, Fernando Hurtado de Mendoza, David A. Rizzieri, Gary J. Schiller, Ruth Pettengell, Jack W. Singer, Geetha Narayanan, Giles W. Boland, Igor Gorbatchevsky, Henry L. Gomez, Lixia Wang, Pier Luigi Zinzani, Christine Kuepfer
Publikováno v:
The Lancet. Oncology. 13(7)
Summary Background Pixantrone dimaleate (pixantrone)—a novel aza-anthracenedione—was synthesised to reduce anthracycline-related cardiotoxicity without compromising antitumour efficacy. We aimed to assess the efficacy and safety of pixantrone ver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a49eef91c94b6743ada3711c7585dcf1
https://pubmed.ncbi.nlm.nih.gov/22652184
https://pubmed.ncbi.nlm.nih.gov/22652184
Autor:
Harrington K; Royal Marsden Hospital, London, UK. kevin.harrington@icr.ac.uk, Berrier A, Robinson M, Remenar E, Housset M, de Mendoza FH, Fayette J, Mehanna H, El-Hariry I, Compton N, Franklin N, Biswas-Baldwin N, Lau M, Legenne P, Kumar R
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2013 May; Vol. 49 (7), pp. 1609-18. Date of Electronic Publication: 2012 Dec 19.
Autor:
Gómez HL; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú. hgomez@inen.sld.pe, Samanéz C, Campana F, Neciosup SP, Vera L, Casanova L, Leon J, Flores C, de Mendoza FH, Casteñeda CA, Pinto JA, Vallejos CS
Publikováno v:
Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2012; Vol. 5 (3), pp. 152-7.
Autor:
Beltran BE; Department of Oncology and Radiotherapy, Edgardo Rebagliati Martins Hospital, Lima, Peru., Castillo JJ, Morales D, de Mendoza FH, Quinones P, Miranda RN, Gallo A, Lopez-Ilasaca M, Butera JN, Sotomayor EM
Publikováno v:
American journal of hematology [Am J Hematol] 2011 Aug; Vol. 86 (8), pp. 663-7.
Autor:
Morales D; Department of Pathology, Edgardo Rebagliati Martins Hospital, Lima, Peru., Beltran B, De Mendoza FH, Riva L, Yabar A, Quiñones P, Butera JN, Castillo J
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2010 Jan; Vol. 51 (1), pp. 66-72.
Autor:
Pivot XB; Medical Oncology University Hospital, Service Oncologie, Boulevard Fleming, Besançon, Inserm U645, France. xavier.pivot@univ-fcomte.fr, Li RK, Thomas ES, Chung HC, Fein LE, Chan VF, Jassem J, de Mendoza FH, Mukhopadyay P, Roché HH
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2009 Nov; Vol. 45 (17), pp. 2940-6. Date of Electronic Publication: 2009 Aug 13.